Fewer Than One-Third of New Patients With RA Receive Disease-Modifying Medications, Study Says - The Center for Biosimilars

Fewer Than One-Third of New Patients With RA Receive Disease-Modifying Medications, Study Says  The Center for Biosimilars

Fewer than one-third of patients newly diagnosed with rheumatoid arthritis (RA) used anti–tumor necrosis factors agents, other biologics, Janus kinase inhibitors, ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases